The adverse events of CDK4/6 inhibitors for HR+/ HER2- breast cancer: an umbrella review of meta-analyses of randomized controlled trials
Pu, Dongqing, Wu, Yue, Xu, Debo, Shi, Guangxi, Chen, Hanhan, Feng, Dandan, Zhang, Mengdi, Li, Jingwei
Published in Frontiers in pharmacology (2024)
Published in Frontiers in pharmacology (2024)
Get full text
Journal Article
Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2− breast cancer: an umbrella review
Pu, Dongqing, Xu, Debo, Wu, Yue, Chen, Hanhan, Shi, Guangxi, Feng, Dandan, Zhang, Mengdi, Liu, Zhiyong, Li, Jingwei
Published in Journal of cancer research and clinical oncology (01.01.2024)
Published in Journal of cancer research and clinical oncology (01.01.2024)
Get full text
Journal Article
Research Status and Hot Trends in Atherosclerosis Genomics between 2010 and 2019
Pu, Dong Qing, Liu, Zheng, Zhou, Chao, Liang, Jia Wei, Hao, Qing Zhi
Published in Zhōngguó yīxué kēxuéyuàn xuébào (28.02.2021)
Published in Zhōngguó yīxué kēxuéyuàn xuébào (28.02.2021)
Get more information
Journal Article